Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

Status:
Recruiting

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

A prospective study of three different doses of Degarelix in late luteal phase of women undergoing ovarian stimulation for IVF

Phase 3

Assisting Nature